Fidelity Investments
NAGE

Fidelity Investments’s Niagen Bioscience NAGE Stock Holding History

Fidelity Investments’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$101K Buy
31,799
+10,270
+48% +$41.7K ﹤0.01% 3976
2026
Q1 		$94.9K Buy
21,529
+4,043
+23% +$21.8K ﹤0.01% 3812
2025
Q4 		$111K Sell
17,486
-972
-5% -$6.76K ﹤0.01% 3705
2025
Q3 		$172K Buy
18,458
+767
+4% +$7.74K ﹤0.01% 3417
2025
Q2 		$255K Buy
17,691
+1,801
+11% +$17.8K ﹤0.01% 3222
2025
Q1 		$110K Buy
15,890
+1,031
+7% +$6.48K ﹤0.01% 3517
2024
Q4 		$78.8K Sell
14,859
-295
-2% -$1.61K ﹤0.01% 3653
2024
Q3 		$55.3K Buy
+15,154
New +$47.7K ﹤0.01% 3739
2023
Q4 		– Sell
-18
Closed -$26 – 5689
2023
Q3 		$26 Sell
18
-10
-36% -$16 ﹤0.01% 5047
2023
Q2 		$43 Sell
28
-11
-28% -$16 ﹤0.01% 5043
2023
Q1 		$60 Buy
39
+8
+26% +$14 ﹤0.01% 4952
2022
Q4 		$52 Buy
31
+19
+158% +$30 ﹤0.01% 4938
2022
Q3 		$0 Sell
12
-11,590
-100% -$18.6K ﹤0.01% 5493
2022
Q2 		$19K Buy
11,602
+6,027
+108% +$11.8K ﹤0.01% 3905
2022
Q1 		$14K Buy
5,575
+5,546
+19,124% +$15.2K ﹤0.01% 4139
2021
Q4 		$0 Sell
29
-642
-96% -$3.47K ﹤0.01% 5030
2021
Q3 		$4K Hold
671
– – ﹤0.01% 3876
2021
Q2 		$7K Sell
671
-24,788
-97% -$216K ﹤0.01% 3655
2021
Q1 		$238K Buy
+25,459
New +$202K ﹤0.01% 2793
2020
Q1 		– Sell
-750
Closed -$3K – 4340
2019
Q4 		$3K Buy
+750
New +$2.67K ﹤0.01% 3528

Other funds holding NAGE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments's NAGE Position: Q2 2026 in Review

Fidelity Investments increased its Niagen Bioscience (NAGE) stake by 48% in Q2 2026, buying an estimated $41.7K and bringing the position to 31,799 shares worth $101K. The position accounts for ﹤0.01% of the portfolio, ranked #3976.

Fidelity Investments first reported a position in NAGE in Q4 2019 and has held it in 20 quarters since. The position peaked at $255K in Q2 2025. 140 funds tracked by Wall St. Rank hold NAGE as of Q2 2026.

  • Fidelity Investments held 31,799 shares of Niagen Bioscience worth $101K as of Q2 2026.
  • Fidelity Investments bought 10,270 Niagen Bioscience shares in Q2 2026, an estimated $41.7K.
  • Niagen Bioscience made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #3976 holding.
  • Fidelity Investments first reported a position in Niagen Bioscience in Q4 2019 and has held it in 20 quarters since.
  • Fidelity Investments's Niagen Bioscience position peaked at $255K in Q2 2025.
  • 140 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.